- Navidea Biopharmaceuticals (NAVB) announces a distribution agreement with
Global Medical Solutions Taiwan for Lymphoseek.
- NAVB says the deal builds "on the growth of Lymphoseek sales in the United States, which continue the positive trends recently reported."
- The company says it will work with its partner to address Taiwanese regulatory requirements and expects "local approval in 2014-15," although Lymphoseek may be available prior to approval "in appropriate situations." (PR)